Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
glaxosmithkline
3
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
3
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
amgen
biogen
cancer immunotherapy
crispr-cas9
cystic fibrosis
deals
eli lilly
fda
indiana blog main
indiana top stories
merck
messenger rna
What
bio
crispr
3
×
roundup
ceo
acquisitions
albert
alliance
big
biggest
bosley's
bosley’s
bourla
bridge
bristol
bucks
buy
calls
cas
changing
color
company
crime
days
departure
drug
editas
exit
future
growing
guiding
hours
imports
katrine
kudos
leaves
maker
maps
measured
medicine
moves
Language
unknown
unset
Current search:
roche
×
crispr
×
glaxosmithkline
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More